Function · Regulatory Affairs

CTD dossiers drafted from your records, reviewed before you file.

SyncIQ drafts Module 1, 2 and 3 and checks each section against ICH and agency guidance before your team reviews it.

A dossier is filed in many markets and maintained for years, as labels and guidance change.

Data secure in your cloud21 CFR Part 11-awareSOC 2 Type II (in progress)ISO 27001 (in progress)Your data never trains foundation modelsTrust and security →

Capabilities

What SyncIQ does.

The flagship

Regulatory Atlas authors and reviews the dossier.

Every value in the QOS links to its Module 3 section, and inconsistencies between the two are flagged.

3.2.P.8.1 · Stability summarySource-linked

The draft

The source

Long-term stability reportPage 4 of 61
  • Storage condition: 25°C ± 2°C / 60% RH ± 5%
  • 36 months · no significant change observed
  • Trend analysis: all CQAs within specification

Click a citation and the originating record opens in split-screen. Field-level lineage, on every value.

Proof points

Results on Module 3 and QOS drafts.

For FDA and EU submissions.

80%
faster to first draft
70–90%
first-draft completeness

Measured in active deployments. Results vary by submission type.

Coverage

What's covered, and the standards behind it.

Built in eCTD or ACTD structure, to the requirements of the authority you file with.

What SyncIQ produces

  • CTD Module 3, from batch records, CoAs and stability data
  • The QOS and Module 2 summaries, each checked against its source
  • Module 1 regional forms for the authorities you file with
  • Variations, renewals and annual reports
  • A new market's filing, from your reference dossier
  • Responses to health authority queries

ANDA, NDA, BLA and IND. Publishing stays in the tools you have already validated.

ACTD

The ASEAN Common Technical Dossier arranges a submission in four parts: administrative data and product information, quality, nonclinical and clinical. Part I holds administrative documents, such as application forms and labeling, that each authority sets.

Post-approval changes

One change, two classifications: prior approval supplement, CBE‑30, CBE‑0 or annual report in the US; Type IA, IB or II variation in the EU, under guidelines applying since January 15, 2026.

Something in regulatory you don't see here? Tell us what's slowing you down →

Start where it hurts.

We'll run Regulatory Atlas live on a section of your dossier.

Request a demo

Your data stays in your environment. Customer data never trains foundation models.